We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Monitoring System Evaluated For Antiphospholipid Syndrome Patients

By LabMedica International staff writers
Posted on 03 Nov 2016
Print article
Image: The Protime InRhythm microcoagulation system kit (Photo courtesy of International Technidyne Corporation).
Image: The Protime InRhythm microcoagulation system kit (Photo courtesy of International Technidyne Corporation).
Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), or often also Hughes syndrome, is an autoimmune, hypercoagulable state caused by antiphospholipid antibodies.

APS provokes blood clots (thrombosis) in arteries and veins as well as pregnancy-related complications such as miscarriage, stillbirth, preterm delivery, and severe preeclampsia. Patients on anticoagulant therapy with vitamin K antagonists (VKA) need frequent International Normalized Ratio (INR) monitoring. The reliability of point-of-care (POC) devices for measuring INR needs rigorous evaluation, particularly in patients with APS.

Scientists at the University of Milan (Italy) compared a POC- INR device versus the laboratory INR measurement for blood samples from 29 APS-positive and 31 APS-negative patients consecutively enrolled. Chromogenic factor X assay was used to evaluate anticoagulation. Bland–Altman difference plot for paired INR (POC versus laboratory) was used to evaluate agreement between the device and the laboratory method. The device INR relationship with factor X chromogenic assay was evaluated by orthogonal regression analysis.

The team evaluated the accuracy of the ProTime InRhythm System (International Technidyne Corporation, Piscataway, NJ, USA), which consists of an instrument and disposable cuvettes. Each cuvette consists of two PT microchannels containing human recombinant thromboplastin to analyze a patient’s sample in duplicate to ensure accurate results, and a third internal control channel that is activated each time a test is performed to verify the integrity of the reagents and proper test procedure.

The scientists found that overall, 97% of the POC device INR measurements were similar to laboratory INR values with an absolute difference less than 0.4 units. Correlation coefficient for the device INR versus factor X was −0.69, (CI 95% −0.80 to −0.52). The authors concluded that The ProTime InRhythm System is an accurate point-of-care device for measuring INR also in patients with and without APS. The study was published in the October 2016 issue of the International Journal of Laboratory Hematology.

Related Links:
University of Milan
International Technidyne Corporation
Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.